Skip to main content
Livermore
Livermore
ZHEN

Profund Advisors LLC

SEC CIK
0001129919
Latest filing
Aug 11, 2026

ARWR holding history

Arrowhead Pharmaceuticals, Inc. in every 13F filed by Profund Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ARWR overviewAll 13F holders of ARWRFull Q2 2026 holdings

Shares (Q2 2026)
22,190
Value
$1.81M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of ARWR by Profund Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202622,190$1.81M<0.1%−17,568−44.2%ReducedHolders
Q1 202639,758$2.49M0.1%+3,216+8.8%AddedHolders
Q4 202536,542$2.43M0.1%+7,108+24.1%AddedHolders
Q3 202529,434$1.02M<0.1%−4,454−13.1%ReducedHolders
Q2 202533,888$535.4K<0.1%−9,857−22.5%ReducedHolders
Q1 202543,745$557.3K<0.1%+13,250+43.4%AddedHolders
Q4 202430,495$573.3K<0.1%−9,259−23.3%ReducedHolders
Q3 202439,754$770.0K<0.1%+7,751+24.2%AddedHolders
Q2 202432,003$831.8K<0.1%−16,957−34.6%ReducedHolders
Q1 202448,960$1.40M0.1%−14,593−23.0%ReducedHolders
Q4 202363,553$1.94M0.1%+9,636+17.9%AddedHolders
Q3 202353,917$1.45M0.1%+6,830+14.5%AddedHolders
Q2 202347,087$1.68M0.1%−5,715−10.8%ReducedHolders
Q1 202352,802$1.34M0.1%+34,803+193.4%AddedHolders
Q4 202217,999$730.0K<0.1%+523+3.0%AddedHolders
Q3 202217,476$578.0K<0.1%−316−1.8%ReducedHolders
Q2 202217,792$626.0K<0.1%−2,567−12.6%ReducedHolders
Q1 202220,359$936.0K<0.1%−2,053−9.2%ReducedHolders
Q4 202122,412$1.49M<0.1%−2,487−10.0%ReducedHolders
Q3 202124,899$1.55M0.1%+16,420+193.7%AddedHolders
Q2 20218,479$702.0K<0.1%−241−2.8%ReducedHolders
Q1 20218,720$578.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.